Suzanne Parker

Suzanne Parker has extensive experience in clinical operations and clinical development. Suzanne is currently serving as the Vice President of Clinical Operations at Morphogenesis, Inc. Prior to this role, they held the position of Senior Director of Clinical Operations at MacroGenics, Inc. from February 2022 to January 2023.

Before that, Suzanne worked at AstraZeneca, where they held multiple roles, including Sr. Global Clinical Operations Program Director, Director of Clinical Development, and Associate Director of Clinical Development. Suzanne started at AstraZeneca in October 2017 and left in July 2022.

Suzanne'searlier experience includes positions at Novartis Pharmaceuticals Corporation, where they served as the Director of US Field Monitoring Operations from September 2013 to August 2017. Before that, they were the Regional Associate Director responsible for the delivery of the US oncology portfolio from May 2009 to September 2013. Suzanne started their career at Novartis as a Sr. Clinical Research Associate in March 2005 and remained in that role until July 2009.

Suzanne Parker obtained their Bachelor of Science (B.S.) degree in Biology/Psychology from Nebraska Wesleyan University, studying from 1987 to 1991.